Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001641172-25-014361
Filing Date
2025-06-09
Accepted
2025-06-09 17:29:53
Documents
10
Period of Report
2025-06-09

Document Format Files

Seq Description Document Type Size
1 6-K form6-k.htm 6-K 32270
2 EX-99.1 ex99-1.htm EX-99.1 1226866
3 EX-99.2 ex99-2.htm EX-99.2 18877
4 EX-99.3 ex99-3.htm EX-99.3 1923
5 EX-99.4 ex99-4.htm EX-99.4 152607
6 GRAPHIC ex99-3_001.jpg GRAPHIC 591844
7 GRAPHIC ex99-3_002.jpg GRAPHIC 379418
8 GRAPHIC ex1_001.jpg GRAPHIC 5197
9 GRAPHIC ex99-2_001.jpg GRAPHIC 8100
10 GRAPHIC ex1_002.jpg GRAPHIC 36595
  Complete submission text file 0001641172-25-014361.txt   2840856
Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7
Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7 843-900-3201
COSCIENS Biopharma Inc. (Filer) CIK: 0001113423 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 251035187
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)